Literature DB >> 8232749

Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease.

P Ince1, N Stout, P Shaw, J Slade, W Hunziker, C W Heizmann, K G Baimbridge.   

Abstract

Calbindin D-28k and parvalbumin are neuronal calcium binding proteins of interest in relation to neurodegenerative diseases. Expression of calbindin and parvalbumin may be one of the determinants of selective vulnerability in these disorders. The distribution of these proteins was surveyed in the normal human motor system and in motor neuron disease (MND) using immunocytochemistry in formalin fixed post-mortem tissues. CNS tissues from 14 MND patients (mean age 61.2 years, mean post-mortem delay 24.6 h) and seven controls (mean age 62.6 years, mean post-mortem delay 25.3 h) were studied. Preliminary studies on the effects of fixation were performed. In normal cases upper and lower motor neurons showed absent expression of both proteins. Several neuronal groups characteristically spared in MND showed varying patterns of immunoreactivity: oculomotor neurons showed parvalbumin staining of the perikaryon; the thoracic preganglionic sympathetic neurons showed calbindin staining in perikarya. Onuf's nucleus showed calbindin staining in the neuropil only. In motor neuron disease a loss of ventral horn interneurons and calbindin immunoreactive processes was observed with no other disease related changes in the spinal cord, brain-stem, or motor cortex. These findings are consistent with the hypothesis that the distribution of these proteins is one determinant of selective vulnerability to the neurodegenerative processes in MND acting via disturbance of neuronal calcium homeostasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232749     DOI: 10.1111/j.1365-2990.1993.tb00443.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  51 in total

Review 1.  Motor neurone disease.

Authors:  P J Shaw
Journal:  BMJ       Date:  1999-04-24

2.  Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease.

Authors:  B K Vanselow; B U Keller
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

3.  Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity.

Authors:  B K Ho; M E Alexianu; L V Colom; A H Mohamed; F Serrano; S H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection.

Authors:  G D Ghadge; J P Lee; V P Bindokas; J Jordan; L Ma; R J Miller; R P Roos
Journal:  J Neurosci       Date:  1997-11-15       Impact factor: 6.167

Review 5.  Effects of methylmercury on spinal cord afferents and efferents-A review.

Authors:  Alexandra Colón-Rodríguez; Heidi E Hannon; William D Atchison
Journal:  Neurotoxicology       Date:  2016-12-29       Impact factor: 4.294

Review 6.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

Review 7.  Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.

Authors:  Laura Ferraiuolo; Janine Kirby; Andrew J Grierson; Michael Sendtner; Pamela J Shaw
Journal:  Nat Rev Neurol       Date:  2011-11       Impact factor: 42.937

8.  Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms.

Authors:  J Roy; S Minotti; L Dong; D A Figlewicz; H D Durham
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant.

Authors:  T L Williamson; L I Bruijn; Q Zhu; K L Anderson; S D Anderson; J P Julien; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.